A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

NCT03380871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Lung Cancer
Nonsquamous Nonsmall Cell Neoplasm of Lung

Interventions

BIOLOGICAL: NEO-PV-01
BIOLOGICAL: Pembrolizumab
OTHER: Adjuvant
DRUG: Carboplatin
DRUG: Pemetrexed

Sponsor

BioNTech US Inc.

Collaborators

[object Object]